Navigation Links
Members of European Parliament discuss food labeling and heart health
Date:6/2/2008

Members of the European Parliament Heart Group meet today, 3 June, in Brussels, to discuss the link between nutrition and cardiovascular diseases and how labelling of food can help people choose products that are better for their hearts and vessels. The European Commission has already made the declaration of the amount of energy, fat, sugars, salt and saturates on food packaging mandatory. Nevertheless, there is no European legislation harmonising diverse national schemes. Consumers often find nutrition labelling confusing and sometimes even misleading.

"Given the alarming rate at which obesity is progressing, especially among children, bringing with it other health related problems such as diabetes, hypertension and heart disease, it seems necessary to insist on giving consumers clear and understandable information in order to help them make better informed dietary choices," explaines Professor Pedro Marques, Spokesperson for the European Association of Cardiovascular Prevention and Rehabilitation (EACPR), a registered body of the European Society of Cardiology (ESC), and speaker at today's MEP Heart Group meeting.

"Front of pack labelling should allow consumers to know at a glance whether a product contributes to their health or not", says Susanne Logstrup, Director of the European Heart Network (EHN). "To achieve this, simplified front of pack labelling of four key nutrients, energy, saturated/trans fats, sugars and salt, must be presented in an easy to understand way. Based on work carried out particularly in the UK, EHN believes that a scheme whereby the quantity of these nutrients are highlighted with a multiple colour coding ('traffic lights'), indicating clearly whether a product contains high, low or medium levels of them, is the best". EHN calls upon MEPs to improve the Commission proposal and put colour coding on mandatory front of pack in the Commission proposal and introduce mandatory back of pack labelling of the 'big eight'
'/>"/>

Contact: Jacqueline Partarrieu
press@escardio.org
33-492-948-627
European Society of Cardiology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. MDwise Enrollment Exceeds 300,000 Members
2. Fitworks Fitness Centers Responds to the Growing Adolescent Obesity Rate by Offering Free Summer Memberships to Teens 13-15 Years of Age
3. UT Southwestern faculty members named Howard Hughes investigators
4. GreatTrainers.com Announces Low-Cost Television and Internet Exposure for Members
5. 34 SEIU Healthcare Leaders Urge UHW-W Members to Join in Support of New Plan to Win Quality Healthcare for All, Build Strength of Healthcare Workers
6. SEIU Members to Politicians: Live Up to Your Promises or We Will Hold You Accountable
7. The Lucian Leape Institute at the National Patient Safety Foundation Announces the Appointment of Two New Members
8. Anthem Blue Cross and Blue Shield in Connecticut Introduces Industrys First Electronic Tool to Help Members Search In-Network Doctors and Hospitals; Transparency Tool to Enable Searches Via Web-Enabled Cell Phones or Hand-Held Devices
9. Cosmetic Bootcamp Announces Record Attendance and Sponsorship and Names Members of Its Board of Advisors
10. Alzheimers Foundation of America Quilt Remembers Moms
11. Top UHW-W Officers Violated Federal Law, Deceived Members in Diverting Millions in Dues Money to Outside Fund
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14Heska Announces Extension of Credit Agreement With Wells Fargo 2Heska Announces Extension of Credit Agreement With Wells Fargo 3Prodigy AutoCode Now Available in 116 Harris Teeter Pharmacies 56299 1Prodigy AutoCode Now Available in 116 Harris Teeter Pharmacies 56299 2Onyx Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference 13865 1Stand Up for Health Care 21 A Labor Day Message From RWDSU President Stuart Appelbaum 56294 1Stand Up for Health Care 21 A Labor Day Message From RWDSU President Stuart Appelbaum 56294 2Stand Up for Health Care 21 A Labor Day Message From RWDSU President Stuart Appelbaum 56294 3
Other Medicine Technology:Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma 2Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma 3Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma 4Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma 5Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 2Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 3Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 4Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 5